tradingkey.logo

Nyxoah SA

NYXH
View Detailed Chart

7.500USD

+0.200+2.74%
Market hours ETQuotes delayed by 15 min
280.70MMarket Cap
LossP/E TTM

Nyxoah SA

7.500

+0.200+2.74%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.74%

5 Days

-1.06%

1 Month

-3.47%

6 Months

-30.56%

Year to Date

-6.25%

1 Year

-8.98%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts
STRONG BUY
Current Rating
13.200
Target Price
80.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
Nyxoah SA
NYXH
6
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(3)
Buy(2)
Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.161
Sell
RSI(14)
43.200
Neutral
STOCH(KDJ)(9,3,3)
35.737
Neutral
ATR(14)
0.365
High Vlolatility
CCI(14)
-99.945
Neutral
Williams %R
72.789
Sell
TRIX(12,20)
-0.124
Sell
StochRSI(14)
72.662
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
7.306
Buy
MA10
7.542
Sell
MA20
7.728
Sell
MA50
7.732
Sell
MA100
7.531
Sell
MA200
8.447
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Ticker SymbolNYXH
CompanyNyxoah SA
CEOMr. Olivier Taelman
Websitehttps://www.nyxoah.com/
KeyAI